MedTrace Logo

Embolization Procedures in the Peripheral Vasculature Using the Magellan™ Robotic System

NCT02369692 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2018-03-01

No results posted yet for this study

Summary

The purpose of this prospective study is to gather procedural use and safety data on the initial use of the Magellan Robotic System with the Magellan Robotic Catheter 6 Fr, Vascular Accessories 6 Fr and Microcatheter Driver This study will focus on, but not be limited to, endovascular embolization procedures in the peripheral vascular, for example, embolization of the splenic and hepatic arteries, uterine arterial embolization (UAE), prostatic arterial embolization (PAE), and trans-arterial chemoembolization (TACE).

The data will be analyzed for medical education, societal presentation and/or publication by the investigator.

Conditions

  • Peripheral Vascular Disease

Interventions

DEVICE

Magellan Robotic 6 Fr Catheter

The Hansen Medical Magellan™ Robotic Catheter 6 Fr (Magellan™)

Sponsors & Collaborators

  • Hansen Medical

    lead INDUSTRY

Principal Investigators

  • Brenda Cayme, RN, BSN · Hansen Medical Inc

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02369692 on ClinicalTrials.gov